Kunkel, M; Krämer, I
Die pharmazeutische ArzneimittelanamneseKrankenhauspharmazie. Bd. 34. H. 6. 2013 S. 280-286
Boone, N; Van der Kuy, H; Scott, M et al.
How to selct a biosimilarEuropean Journal of Hospital Pharmacy. Bd. 20. H. 10. 2013 S. 275-286
Boone, Niels; van der Kuy, Hugo; Scott, Mike et al.
How to select a biosimilarEUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE. Bd. 20. H. 5. 2013 S. 275-286
Eberlin, M.; Otto, G.; Kraemer, I.
Increased Medication Compliance of Liver Transplant Patients Switched From a Twice-Daily to a Once-Daily Tacrolimus-Based Immunosuppressive RegimenTRANSPLANTATION PROCEEDINGS. Bd. 45. H. 6. 2013 S. 2314-2320
Eberlin, M; Otto, G; Krämer, I
Increased Medication Compliance of Liver Transplant Patients Switched from a Twice-Daily to Once-Daily Tacrolimus-Based Immunosuppressive RegimenTransplantation Proceedings. Bd. 46. H. 6. 2013 S. 2314-2320
Kraemer, Irene; Walz-Jung, Hannah; Stanko, Christine et al.
Physicochemical compatibility of nebuliser solution admixtures containing colistimethate and hypertonic saline or colistimethate, fluticasone-17-propionate, ipratropium bromide and salbutamol sulfateEUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE. Bd. 20. H. 1. 2013 S. 36-41
Wollstadt, A; Krämer, I; Kamin, W
Physicochemical compatibility of nebulizable drug admixtures containingDie Pharmazie. Bd. 68. H. 9. 2013 S. 744-748
Klemmer, A; Krämer, I; Kamin, W
Physicochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistimethate or Hypertonic SalineInternational Journal of Pharmaceutical Compounding. Bd. 17. H. 3. 2013 S. 254-261
Wollstadt, A.; Kraemer, I.; Kamin, W.
Physicochemical compatibility of nebulizable drug admixtures containing colistimethate and tobramycinPHARMAZIE. Bd. 68. H. 9. 2013 S. 744-748
Gilcher, T; Heeb, R; Krämer, I
Physikalisch-chemische Stabilität einer Metoprolol-Injektionslösung 1 mg/ml, 50 mlKrankenhauspharmazie. Bd. 34. H. 11. 2013 S. 524-525